Company
Headquarters: Vancouver, BC, Canada
CEO: Mr. Joel Shacker
C$15.6 Million
CAD as of Jan. 1, 2024
US$11.8 Million
Company | Market Cap (USD) |
---|---|
Intuitive Surgical, Inc. | $113.81 B |
EssilorLuxottica SA | $90.57 B |
Becton, Dickinson and Company | $70.33 B |
HOYA Corp | $43.39 B |
Alcon Inc. | $37.65 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. It focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. The company manufactures CannaStrips, which are infused strips, as well as produces distillate oils, flowers, and resins. It also offers consulting, financing, and micro cultivation services, as well as operates medical, health, and wellness clinics. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Core One Labs, Inc. has the following listings and related stock indices.
Stock: CSE: COOL wb_incandescent
Stock: OTC: CLABF wb_incandescent